These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

754 related items for PubMed ID: 26464143

  • 1. Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    Han SB, Lee SC, Lee SY, Jeong DC, Kang JH.
    BMC Infect Dis; 2015 Oct 13; 15():414. PubMed ID: 26464143
    [Abstract] [Full Text] [Related]

  • 2. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
    Cho YH, Jung SI, Chung HS, Yu HS, Hwang EC, Kim SO, Kang TW, Kwon DD, Park K.
    Int Urol Nephrol; 2015 Jul 13; 47(7):1059-66. PubMed ID: 26026972
    [Abstract] [Full Text] [Related]

  • 3. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in febrile neutropenic children.
    Han SB, Jung SW, Bae EY, Lee JW, Lee DG, Chung NG, Jeong DC, Cho B, Kang JH, Kim HK, Park YJ.
    Microb Drug Resist; 2015 Apr 13; 21(2):244-51. PubMed ID: 25398058
    [Abstract] [Full Text] [Related]

  • 4. Carbapenem-resistant Klebsiella pneumoniae urinary tract infection following solid organ transplantation.
    Brizendine KD, Richter SS, Cober ED, van Duin D.
    Antimicrob Agents Chemother; 2015 Jan 13; 59(1):553-7. PubMed ID: 25385105
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Extended spectrum beta lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern -A hospital based cross sectional study.
    Fernando MM, Luke WA, Miththinda JK, Wickramasinghe RD, Sebastiampillai BS, Gunathilake MP, Silva FH, Premaratna R.
    BMC Infect Dis; 2017 Feb 10; 17(1):138. PubMed ID: 28187754
    [Abstract] [Full Text] [Related]

  • 7. Urinary Tract Infections in Kidney Transplant Patients Due to Escherichia coli and Klebsiella pneumoniae-Producing Extended-Spectrum β-Lactamases: Risk Factors and Molecular Epidemiology.
    Espinar MJ, Miranda IM, Costa-de-Oliveira S, Rocha R, Rodrigues AG, Pina-Vaz C.
    PLoS One; 2015 Feb 10; 10(8):e0134737. PubMed ID: 26237422
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of fosfomycin and other antimicrobials against uropathogenic Escherichia coli and Klebsiella pneumoniae at a tertiary care center in Lebanon.
    Araj GF, Jaber FA.
    J Med Liban; 2012 Feb 10; 60(3):142-7. PubMed ID: 23198454
    [Abstract] [Full Text] [Related]

  • 9. Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland.
    O'Kelly F, Kavanagh S, Manecksha R, Thornhill J, Fennell JP.
    BMC Infect Dis; 2016 Nov 03; 16(1):620. PubMed ID: 27806687
    [Abstract] [Full Text] [Related]

  • 10. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
    Lee J, Pai H, Kim YK, Kim NH, Eun BW, Kang HJ, Park KH, Choi EH, Shin HY, Kim EC, Lee HJ, Ahn HS.
    J Antimicrob Chemother; 2007 Sep 03; 60(3):629-37. PubMed ID: 17599919
    [Abstract] [Full Text] [Related]

  • 11. The efficacy of non-carbapenem antibiotics for the treatment of community-onset acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli.
    Park SH, Choi SM, Chang YK, Lee DG, Cho SY, Lee HJ, Choi JH, Yoo JH.
    J Antimicrob Chemother; 2014 Oct 03; 69(10):2848-56. PubMed ID: 24928854
    [Abstract] [Full Text] [Related]

  • 12. Comparative effectiveness of flomoxef versus carbapenems in the treatment of bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae with emphasis on minimum inhibitory concentration of flomoxef: a retrospective study.
    Lee CH, Su LH, Chen FJ, Tang YF, Li CC, Chien CC, Liu JW.
    Int J Antimicrob Agents; 2015 Dec 03; 46(6):610-5. PubMed ID: 26387064
    [Abstract] [Full Text] [Related]

  • 13. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Kuzucu C, Yetkin F, Görgeç S, Ersoy Y.
    Mikrobiyol Bul; 2011 Jan 03; 45(1):28-35. PubMed ID: 21341156
    [Abstract] [Full Text] [Related]

  • 14. Impact of Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae on the outcome of community-onset bacteremic urinary tract infections.
    Yang YS, Ku CH, Lin JC, Shang ST, Chiu CH, Yeh KM, Lin CC, Chang FY.
    J Microbiol Immunol Infect; 2010 Jun 03; 43(3):194-9. PubMed ID: 21291846
    [Abstract] [Full Text] [Related]

  • 15. Cefoxitin: An alternative to carbapenems in urinary tract infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae.
    Mambie A, Vuotto F, Poitrenaud D, Weyrich P, Cannesson O, Dessein R, Faure K, Guery B, Galpérine T.
    Med Mal Infect; 2016 Jun 03; 46(4):215-9. PubMed ID: 27210283
    [Abstract] [Full Text] [Related]

  • 16. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
    Liu HY, Lin HC, Lin YC, Yu SH, Wu WH, Lee YJ.
    J Microbiol Immunol Infect; 2011 Oct 03; 44(5):364-8. PubMed ID: 21524974
    [Abstract] [Full Text] [Related]

  • 17. Pediatric community acquired urinary tract infections due to extended-spectrum beta-lactamase versus non-extended-spectrum beta-lactamase producing bacteria.
    Alsubaie MA, Alsuheili AZ, Aljehani MN, Alothman AA, Alzahrani AS, Mohammedfadel HA, Alnajjar AA.
    Pediatr Int; 2023 Oct 03; 65(1):e15620. PubMed ID: 37735838
    [Abstract] [Full Text] [Related]

  • 18. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
    Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW.
    Antimicrob Agents Chemother; 2004 Dec 03; 48(12):4574-81. PubMed ID: 15561828
    [Abstract] [Full Text] [Related]

  • 19. Ceftibuten plus amoxicillin-clavulanic acid for oral treatment of urinary tract infections with ESBL producing E. coli and K. pneumoniae: a retrospective observational case-series.
    Cohen Stuart J, Leverstein-Van Hall M, Kortmann W, Verlind J, Mulder F, Scharringa J, Fluit A, Ekkelenkamp M.
    Eur J Clin Microbiol Infect Dis; 2018 Oct 03; 37(10):2021-2025. PubMed ID: 30117050
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of non-carbapenem antibiotics for pediatric patients with first febrile urinary tract infection due to extended-spectrum beta-lactamase-producing Escherichia coli.
    Abe Y, Inan-Erdogan I, Fukuchi K, Wakabayashi H, Ogawa Y, Hibino S, Sakurai S, Matsuhashi K, Watanabe Y, Hashimoto K, Ugajin K, Itabashi K.
    J Infect Chemother; 2017 Aug 03; 23(8):517-522. PubMed ID: 28528936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.